Rat Spinal Cord Motor Neurons (RSCMN)

Overview

Rat Spinal Cord Motor Neurons (RSCMN) is a cell model used for research applications where physiologically relevant identity and donor background support interpretation of experimental readouts. Rat Neurons derived from Spinal Cord (Spinal Cord Motor) within the Nervous system.

The spinal cord is the most important structure between the body and the brain. The spinal cord extends from the foramen magnum where it is continuous with the medulla to the level of the first or second lumbar vertebrae [1] . The spinal cord is composed of tubular bundles of nervous tissues and support cells. Extending from the occipital bone of the skull until it terminates near the second lumbar vertebra, the spinal cord transmits neural signals from the motor cortex to the body, and from the afferent fibers of the sensory neurons to the sensory cortex. It is also a center for coordinating many reflexes and contains reflex arcs that can independently control reflexes [2] . Studies using spinal cord neurons will allow a better understanding of the disease mechanisms, physiopathologies, and advancement in drug development and therapies. Cultures of spinal cord neurons can be applied for a variety of experiments including cytotoxicity test, immunocytochemistry staining, live cell imaging and co-culture, etc. iXCells Biotechnologies provides high quality Rat Spinal Cord Motor Neurons (RSCMN), which are isolated from D16 rat embryo spinal cord and cryopreserved at P0, with >0.2 million cells in each vial. When cultured under the recommended conditions, RSCMN arborize and form complex neurite network since about 4-5 days till one week. RSpN stain positive for Tuj1 and MAP2. RSCMN are negative for mycoplasma, bacteria, yeast, and fungi. Figure 1. (A) Phase contrast image of Rat Spinal Cord Motor Neurons (RSCMN) (DIV 4). (B) RSCMN are positive for β III-Tubulin (TUJ1) and MAP2 as shown by immunofluorescence staining.

Key elements and design rationale

• Cell identity: Neurons (Primary Cells)
• Source context: Spinal Cord; Spinal Cord Motor; Nervous
• Biosafety level: BSL-1 (follow your institution’s biosafety program and local regulations)

Product-specific elements (such as tissue source, donor background, and cell classification) help frame how results should be interpreted across assays and experimental conditions.

Biological background

Neural and glial cell models support studies of neuronal signaling, synaptic biology, neuroinflammation, and cell-type–specific responses to injury or disease-relevant stimuli.

Across primary and specialty cell models, experimental outcomes can be influenced by donor heterogeneity, passage history, confluence, and media composition. For interpretation, it is common to validate key markers or functional phenotypes in the user’s assay context and to document culture variables consistently.

Research relevance and current trends

• Increasing use of primary and specialty cells to improve translational relevance for target biology and phenotypic screening.
• Adoption of 3D culture formats and co-culture systems to better capture tissue microenvironments and cell–cell interactions.
• Integration of functional readouts with single-cell and multi-omics profiling to connect phenotype with molecular state.
• Growth of human-relevant neural models (including glial components) to study circuit- and inflammation-linked phenotypes.

Common research applications

• Profile identity markers by flow cytometry or immunostaining in cultured cells
• Quantify neurite outgrowth and synaptic marker profiles in neural cultures
• Quantify functional responses to defined stimuli relevant to the model system
• Compare baseline phenotype across donors/conditions using gene expression profiling
• Measure neuroinflammatory signaling in neuron–glia or microglia-enriched models

Interpretation typically focuses on how a perturbation (e.g., cytokine exposure, metabolic stress, genetic manipulation, or compound treatment) shifts marker profiles or functional readouts relative to an appropriate control matched for donor and culture variables.

Notes for experimental interpretation

• Donor-to-donor heterogeneity can influence baseline phenotype and treatment response; include biological replicates when feasible.
• Passage number, confluence, and media composition can shift gene expression and functional readouts; track and report these variables consistently.
• Contamination control (including routine mycoplasma monitoring) supports reproducibility in downstream assays.
• Use appropriate negative/positive controls for the readout (e.g., unstimulated controls, pathway agonists/antagonists) to contextualize observed changes.

SKU:BHC18500115

Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.